Selective and potent agonists for estrogen receptor beta derived from molecular refinements of salicylaldoximes
- 1 June 2011
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 46 (6) , 2453-2462
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (NIH P41 RR001081, PHS R37 DK015556, NRSA F30 ES016484-01, T32 GM070421)
This publication has 46 references indexed in Scilit:
- Estrogen receptors similarly mediate the effects of 17β-estradiol on cellular responses but differ in their potenciesEndocrine, 2010
- Intra- and Intermolecular Interaction Inducing Pyramidalization on Both Sides of a Proline Dipeptide during Isomerization: An Ab Initio QM/MM Molecular Dynamics Simulation Study in Explicit WaterJournal of the American Chemical Society, 2009
- The role of estrogens and estrogen receptors in normal prostate growth and diseaseSteroids, 2008
- Estrogen receptor beta in the brain: From form to functionBrain Research Reviews, 2008
- Impact of Estrogen Receptor β on Gene Networks Regulated by Estrogen Receptor α in Breast Cancer CellsEndocrinology, 2006
- Synthesis of Anthranylaldoxime Derivatives as Estrogen Receptor Ligands and Computational Prediction of Binding ModesJournal of Medicinal Chemistry, 2006
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996
- Palladium-Catalyzed Cross-Coupling Reactions of Organoboron CompoundsChemical Reviews, 1995
- "Ortho Effects" of the Halogen Atoms in the Reactions of 3-Bromo-2,6-dimethoxybenzaldehyde and 2-Chloro-3-bromo-6-methoxybenzaldehyde with Aluminium Chloride.Acta Chemica Scandinavica, 1970